CELLULAR RECOGNITION BY MOUSE LYMPHOCYTES IN VITRO : I. DEFINITION OF A NEW TECHNIQUE AND RESULTS OF STIMULATION BY PHYTOHEMAGGLUTININ AND SPECIFIC ANTIGENS by Adler, W. H. et al.
CORhIELL  UN~VERSI,~  ~, 
t'4 F-,£)ICAL COLLEGE 
1300  Yore  Ave..  N.Y.C . 
JUN  2  1970 
M.E aC, ¢ 
CELLULAR  RECOGNITION  BY  MOUSE  LYMPHOCYTES 
IN  VITRO 
I.  DEFINITION  OF  A  NEW  TECHNIQUE  AND  RESULTS  OF  STIMULATION 
BY  PHYTOHEMAGGLUTININ AND  SPECIFIC  ANTIGENS* 
BY W. H. ADLER,$ M.D., T. TAKIGUCHI, M.D., B. MARSH, M.D,, 
A~D R. T.  SMITH, M.D. 
(From the Tumor Biology  Unit, Department of Pathology,  College of Medicine, 
University  of Florida,  Gainesville,  Florida  32601) 
(Received  for  publication  3  December  1969) 
The lymphoid cells of man, rat,  guinea pig, rabbit, and other species respond in 
vitro  to  a  variety  of  specific and  nonspecific stimuli. Metabolic and  morphologic 
changes in a stimulated cell population lead to cell division and elaboration of several 
biologic  potent effector substances into the medium (1, 2). Despite the obvious genetic 
and  operational advantages o[ the laboratory mouse for in vitro studies of  cellular 
recognition, use  of this species has been limited by the  short life span  and lack of 
sustained stimulated cell division permitted by tissue culture conditions. 
Dutton  (3)  and Heumer  and  colleagues (4)  have  devised the most successful in 
vitro culture methods for mouse spleen cells; the former is now being widely used for 
the investigation of primary antibody synthesis in mouse spleen cell populations, and 
the latter for the study of cell to cell interaction. In other  studies,  cell division was 
shown  to  follow phytohemagglutinin  (PHA)  t  stimulation of  mouse  lymphoid cells 
(5-7)  and production of various effector substances followed alloantigen and PHA 
stimulation.  (8-11)  On  the  other  hand,  no  culture medium  capable of  supporting 
extended viability and stimulation of mouse lymphoid cells has been described (12). 
This series of papers describes and characterizes in detail a technically simple 
and dependable method of cultivating mouse lymphoid cells in vitro, and de- 
scribes the results of studies of stimulation and other events of cellular recogni- 
tion which the technique permits. This paper reports methods and requirements 
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for  mitogenic  stimulation  of  mouse  lymphoid  cells  with  phytohemagglutinin 
and  certain  specific antigens.  Subsequent  papers  in  this  series  concern the  re- 
sults  of mixed cell reactions  involving a  variety of strong  and  weak histocom- 
patibility  antigens  (13),  characterization  of  mitogenic  factors  elaborated  in 
mixed  cell reactions,  and  stimulation  by  tumor  specific  transplantation  anti- 
gens3 A  preliminary report  of some early results  of this investigation has  been 
made elsewhere  (14,  15). 
Materials and Methods 
Tissue Culture Medium.--Throughout the experiments reported, the tissue culture medium 
employed was  a  complete medium  designated  Roswell Park  Memorial Institute  (RPMI) 
1640, obtained from Grand  Island Biological Co.,  Grand  Island,  N.  ¥.  For certain experi- 
ments,  the medium was supplied deficient in arginine and asparagine and these amino acids 
were added as required by the experiments. All media employed contained 100 units of peni- 
cillin and 100/zg streptomycin per ml. 5% flesh human serum which had been heated at 56°C 
for 30 min was added before use. Lots of complete medium, thus constituted, were always used 
for experiments within 24 hr of preparation. It was soon established that human serum varies 
considerably in its capacity to support lymphocyte stimulation; thus, the serum from a single 
donor was used for each complete experiment. Under identical conditions of cell origin and 
number,  and  of stimulus,  medium containing serum from a  single  donor gave test  results 
having a high order of day to day and week to week reproducibility (see text). 
Culture Conditions.--Each  tube always contained  3.0 ml of medium, and,  except where 
indicated, 15 X  106 mouse spleen leukocytes. The tubes (13 X  100, Falcon plastic, No. 2037, 
disposable screw-capped type) were incubated at 37°C,  loosely capped, for varying periods 
of time, in a 5% CO2 in air atmosphere and 80% humidity, inclined at a  10  ° angle. 
Animals and Cell Preparatien.--Mice  used for these studies were either purchased from 
Jackson Laboratories,  Bar Harbor,  Maine,  or derived from our own inbred lines,  originally 
obtained as pedigreed stock, and kindly supplied by Jackson Laboratories. Strains employed 
A/J; C57B1/6;  C57B1/10,  and its congenic sublines B10-M, B10-LP, and B10-D2; BALB/C; 
CBA; and DBA-2. F1 hybrids were all obtained from Jackson Laboratories, together with the 
appropriate parental strains to be included in a single experiment. 
Cells were obtained by removing the spleen,  thymus, or lymph nodes under sterile condi- 
tions.  Each organ was gently minced with scissors and the tissue fragments screened through 
60-mesh stainless steel gauze into the complete tissue culture medium. The cells were drawn 
through a 25 gauge needle to produce a suspension  of single ceils. The cells were then counted 
and distributed to the culture tubes. The spleen cell suspension  usually consisted of about 95% 
mononuclear cells. 
Assay  of Anti-Mouse  Antibody.--Anti-mouse  erythrocyte  agglutinins  (a-MRBC)  were 
assayed by adding 0.25 ml of 10% washed A/J erythrocytes to 0.25 ml of serial two-fold dilu- 
tions of serum in phosphate-buffered  saline,  pH 7.2;  the mixture was incubated  120 rain at 
37°C and  the hemagglutinin titer was read  visually after 18  hr at 4°C. For studies in which 
the a-MRBC was eluted from mouse erythrocytes (MRBC) for further investigation, serum 
from a donor having a  1:20 titer of a-MRBC was incubated at 37°C for 30 rain and at 4°C 
for 18 hr, with an equal volume of thrice washed A/J erythrocytes. The agglutinin was eluted 
from these erythrocytes after washing twice with buffered saline, either by adding one volume 
of ether at 37°C according to the method of Rubin (16) or by heating the cells in 7% bovine 
albumin at 56°C for 15 rain by the method of Landsteiner and Miller (17). The supernatants 
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from these procedures were collected by centrifugation, concentrated, and used to determine 
cytotoxicity, hemolysis, and attachment to mouse lymphocyte membranes by the fluorescent 
antibody technique. Cytotoxicity was assayed by the method of Gorer and O'Gorman  (18) 
and membrane immunofluorescence by the method of M611er (19).  The eluted antibody was 
identified by the Ouchterlony technique employing various reagent anti-human immunoglob- 
ulins prepared in this laboratory. 
Thymectomy.--Thymectomy was performed in newborn mice by the method described by 
Sjodin, et al (20) and verified as complete by gross examination when the animals were sacrificed 
for the experiments reported. 
PttA  Stimulation.--Phytohemagghitinin  P  (PHA-P,  Difco)  was  employed  as  supplied, 
suspended in sterile water, at 10 microliters per tube, except as indicated in the text. Marked 
leukoagglutination was always evident in cultures stimulated with this reagent. 
BCG Immunization  Procedures and PPD Stimulation.--In experiments in which BCG sen- 
sitization was attempted, 0.05 ml of a 12-day old culture of bacillus Calmette-Gu~rin, obtained 
from Dr. Joseph Shands, Department of Microbiology, University of Florida, was given sub- 
cutaneously; spleen or other cells were later harvested at varying intervals. The in vitro test 
for stimulation of these cells was identical to that for PHA,  except that the cultures were 
terminated at 72 hr; 24 hr after adding 3H-thymidine. Purified protein derivative (PPD) was 
obtained from Merck, Sharp & Dohme (Lot No. 4492), West Point, Pa. 
Human dialysate transfer factor was prepared by the method of Lawrence (21) from the 
peripheral leukocytes of  an individual known  to  be strongly tuberculin-positive from skin 
testing. The dialysate obtained was lyophilized and reconstituted in tissue culture medium for 
the experiments described.  Its effectiveness was  verified by its capacity  to  render human 
peripheral lymphocytes from a  tuberculin-negative donor reactive to  PPD  in vitro by the 
technique of Fireman, et al. (22). A single amount of the dialysate, 0.1 ml containing transfer 
factor derived from 6  X  106 lymphocytes was employed. It was incubated with 15  X  106 
mouse spleen cells for 30 rain at 37°C, followed by washing, and addition of medium and PPD 
as indicated. 
Sheep Erythrocyte Immunization  Procedures and  SRBC  Stroma Stimulation.--Mice were 
immunized by a single intravenous injection of 0.1 ml of a 50% suspension of sheep erythro- 
cytes  (SRBC)  and spleen cells were taken at varying intervals for in vitro stimulation with 
SRBC stroma. Animals designated hyperimmune had received three injections of SRBC over 
a 3-wk interval before sacrifice.  The SRBC stroma were prepared by hypotonic lysis and re- 
peated washing of fresh SRBC, then lyophillized and used for in vitro stimulation after recon- 
stitution in  tissue culture medium. 
Method of Assaying Cell Stimulation 
Euchrysine staining:  Cells from experimental and control tubes were suspended by vigorous 
mechanical agituation; one drop of the suspension was taken and added to one drop of 1 : 100,000 
final dilution of euchrysine (K  & K  Laboratories, Inc., Plainview, N. Y.) in buffered saline, 
according to the method of Allison and Mallucci (23). The resultant preparation was examined 
immediately by fuorescent microscopy at a  magnification of 400 times. 
Acid  phosphatase staining:  Acid phosphatase staining was  performed  on  acetone:fixed 
smears of stimulated and unsfimulated cells at varying intervals by the method of Burstone 
(24). The cells were scored by counts of 100 cells at 1000 times magnification, as having zero 
or one (negative), or more than one (positive) phosphatase positive granules in the cytoplasm. 
Blast  transformation: The  occurrence of  blast  transformation was  determined  by  light 
microscopy  of  Wright-Giemsa stained  cell preparations,  at  intervals  in  culture  using  the 
morphologic criteria described by Chessin, et al (25) for human cell populations. The results 
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3H-thymidine  incorporation assay:  In all tests, 1.0 microcurie (#Ci) of tritiated thymidine 
(3H-thymidine; Schwarz Biochemical, specific  activity 1.9 curie/mmole; 1 #Ci per 2 #1) was 
added  to each tube for the final 24 hr of culture, after which the cultures were terminated. 
At termination, the tubes were centrifuged at  1,500  rpm,  the resultant cell button washed 
twice with cold 0.15 M NaC1 and twice with 5% trichloroacetic acid (TCA) at 4°C. After this, 
the precipitates were washed once with absolute methanol. Mter TCA precipitation and wash- 
ing,  the precipitates were  transferred to glass  tubes and allowed  to  dissolve in 0.25  ml of 
nuclear Chicago solubilizer (NCS) for 2 hr at 45  ° C.  15 ml of scintillation fluid  (toluene, con- 
taining p-bis[2-(5-phenyloxazolyl)]benzene (POPOP)  100  mg/liter  and  2,5~diphenyloxazole 
(PPO) 5 g/liter) was then added to the solubilized  precipitate. The solution was transferred to 
screwtop vials and counted in a Beckman Model CPM-100 liquid scintillation counter after 24 
hr accommodation. The counting efficiency  under the conditions described is 80%. 
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FIG.  1. Viability of C57B1/6 spleen cells in RPMI  1640 culture medium plus 5% human 
serum. In these experiments, 15 >  106 C57B1/6 spleen cells per tube were incubated for the 
indicated period of time and viability determined by trypan blue exclusion. The points shown 
represent: cultures of 15  X  106 cells with no added medium (0); cultures of 15  X  106 cells 
fed  by adding one-half volume of medium every other day,  beginning on day 2  (Q).  The 
values shown are means and ranges of 5-I0 tubes. 
This technique gave replicate values consistently within 5 to 10%. The data obtained are 
presented as average values if duplicates only were performed; as mean value and range of 
values if 3 to 5 replicate tubes were included; or as a mean value plus or minus (4-) the stand- 
ard error (sE) of the mean when 6 to 12 tubes were included. 
R ESU LTS 
Characterization  oJ the Culture Conditions.--The only medium of many tried 
which provided  conditions for  in vitro stimulation consisted  of  an amino  acid 
rich tissue culture fluid, RPMI  1640, to which was added 5 %  fresh, heated hu- 
man  serum.  The survival of mouse spleen cells from all strains cultured in this 
medium  had  a  characteristic  pattern  exemplified  by  that  shown  in  Fig.  1. 
Roughly  linear  decrease  in  viability occurred  during  the first  5  to  7  days;  at 
that  time the cultures  contained about  30%  viable cells.  After  that,  a  slower ADLER,  TAKIGUCHI~  MARSH,  AND  SMITH  1053 
rate of decline in viability was observed; 20-30% of cells survived 10-12 days. 
After 10 days, the proportion of cells surviving often increased and some rela- 
tively long-term cultures have been established. 
The proportion of surviving cells in the first 10 days of culture could be in- 
creased (Fig. 1) by adding increments of fresh medium at 48 hr intervals. The 
actual number of cells surviving under the conditions of this experiment are 
more difficult to determine because of the variable proportion which adhere to 
the vessel during the culture period. In general, however, the decline of cell 
numbers under the culture conditions illustrated in Fig.  1, roughly paralleled 
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FIG.  2.  Time-course of PHA stimulation of A/J spleen cells.  15  X  106  cells per tube in 
3  ml were incubated with or without PHA for the indicated  periods of time. SH-thymidine 
incorporation was determined for the last 24 hr of each period. Per cent blast transformation 
and  euchrysine staining were determined on the indicated  day.  The values given represent 
the means of 3-5 replicate tubes. 
that of viability. The culture conditions adopted for subsequent studies con- 
sisted of 15 X  106 cells in 3 ml of RPMI 1640 with 5 % fresh, heat inactivated 
human serum added. 
When PHA was added to replicate tubes of mouse spleen cells in this medium, 
the  same  constellation of  effects was  observed which  has  been  reported for 
lymphoid cells of other species. The time course of several of these effects is 
illustrated by the experiments shown in Fig. 2. By 24 hr an increase in the pro- 
portion of cells containing either euchrysine-positive supravitally stained lyso- 
somes  or  acid phosphatase-containing  granules  appeared  in  the  PHA-stimu- 
lated cells. Positive cells increased over the 72 hr period of culture to a maximum 
of 30-40 % in the case of euchrysine granules and nearly 100 % in the case of 1054  CELLULAR  RECOGNITION  BY  LY~PHOCYTES  IN  VITRO.  I 
acid phosphatase granules.  During  this  interval,  however, the  discrimination 
between  the control  and  the stimulated cultures  by  these  assays  decreased, 
since numbers of granules rapidly increased in the unstimulated cells also. This 
proved to limit the practical values  of both the euchrysine  and phosphatase 
granule assay for discrimination quantitatively between the stimulatory capa- 
bility of different mitogenic substances. 
In addition to the expected increase in number and size of lysosomal granules 
in stimulated mouse cells,  blast transformation, as judged by the morphologic 
TABLE I 
Time-Course of Stimulation  of A/J Spleen Cells by PHA, in Rdationship  to Lysosome 
Appearance, Blast Transformation, and 3tt-Thymidine  Incorporation* 
Acid phos- 
Euchrysine-  phatase- 
positive granules  positive  Blast trans-  aH=thymidine 
Time intervals and conditions  (mean of cells  granules  formation (mean  incorporation (mean 
with one  (mean of cells of positive cells)  cpm per tube)$ 
of the  experiment  or more)  with more 
than  one) 
Control  PHA  Control PHA  Control  PHA  Control  PHA 
%  %  %  %  %  %  cpm  cpr~ 
24  hr;  3H-thymidlne added  at  3.0  7.7  13  88  0.6  4.3  44,661  44,522  1.0 
beginning 
48  hr;  3tt-thymidine added  at  4.6  26.0  48  98  2.7  33.2  12,911  237,015  18.3 
24 hr 
72  hr;  ~H-thymidine  added  at  4.7  26.2  --  --  5.3  38.9  15,761  178,969  11.4 
48 hr. 
96  hr;  aH-thymidine added  at  5.8  25.7  --  --  3.6  34.4  34,228  119,003  3.5 
72 hr. 
72 hr; 8H-thymidine added and  5.5  30.0  --  --  2.9  36.7  18,916  333,887  17.6 
medium changed at 48 hr 
96  hr;  3H-thymidine added  at  5.5  24.0  --  --  3.5  34.2  41,633  243,638  5.9 
72 hr; medium changed at 48 
hr 
* In this experiment, 15 X  10 6 A/J spleen cells per tube were examined at intervals for 
the four parameters indicated. See Materials and Methods for procedure. The medium change 
was accomplished by replacing one-half  of the culture fluid with fresh medium. 
:~ Mean values are of duplicate tubes. 
criteria described for stimulated human cells (25)  occurred in 30-40%  of the 
cell populations by the end of the 2nd day of culture. This proportion rose only 
slightly thereafter. In contrast,  unstimulated cells showed less than 5 %  blast 
transformation during 10 days of culture. 
The time course of blast transformation was paralleled roughly by incorpora- 
tion  of 3H-thymidine as  determined  at  intervals in  both stimulated  and  un- 
stimulated cells. Maximum incorporation after PHA stimulation occurred be- 
tween 24 and 48 hr and declined thereafter. Unstimulated cells have a high de- 
gree  of incorporation  of 3H-thymidine in  the  first hours  of culture  but  this 
declines to reach a steady state later in cultivation. ADLER~ TAKIGUCHI,  MARSH, AND  SMITH  1055 
Experiments of similar type, but illustrating the effect of adding fresh tissue 
culture medium to the system at 48 hr, are shown in Table I. Note that addi- 
tional 3H-thymidine incorporation followed the  addition  of fresh medium  in 
PHA-stimulated cultures, but not in control cultures. However, no significant 
increase in the proportion of lymphoblasts in the culture or of granules stained 
by euchrysine was seen. This table also shows that the ratio of incorporation of 
3H-thymidine in stimulated cell cultures divided by that of unstimulated cell 
cultures in the PHA system is maximal at 48 hr and declined after that time. 
These time course studies of PHA stimulation of mouse lymphoid cells give 
data comparable to those reported for human  and rat systems (26,  27). The 
interval between establishment of the culture and the beginning of DNA syn- 
TABLE  II 
Dose Response Rdationshlp between PHA Concentration and 3H-Thymidine 
Incorporation by A/J Spleen Cells* 
Ratio of 
PHA-P added per  *H-thymidine  incorporation (mean  and range cpm per tube)  incorporation: 
tube  PHA/control 
microliters  @m  ~m 
0  2,216  (1,989-2,436) 
1  79,685  (71,534-85,798)  35.9 
5  94,992  (91,498-100,303)  42.9 
10  122,952  (119,091-129,806)  55.5 
25  50,587  (48,561-52,142)  22.8 
50  16,197  (14,173-18,967)  7.3 
100  4,241  (4,0744,408)  1.9 
* In this experiment, varying amounts of PHA, as indicated, were added to  15  X  106 
spleen cells, incubated for 24 hr, 3H-thymidine was then added and the experiment terminated 
at 48 hr. The data shown represent mean and range for 3-5 replicate tubes. 
thesis was somewhat shorter, however, and an earlier maximum rate of synthesis 
of DNA was achieved in comparison to these other systems. 
These  experiments provided the  basis  for establishing  a  standard  culture 
period of 48 hr for PHA stimulation; assaying stimulation based upon tritiated 
thymidine incorporation during the final 24 hr of this period. The agreement 
between replicate tubes in such experiments was high; usually on the order of 
5%. 
The relationship between PHA concentration and thymidine incorporation 
in several different strains of mouse spleen cells was examined across a 100-fold 
range  of PHA  concentrations. Results  of a  typical experiment are  shown  in 
Table II. Optimal stimulation, both in terms of total thymidine incorporation 
and discrimination as expressed by the ratio of incorporation was greatest at 10 
microliters per tube. Amounts of PHA greater than this gave decreasing degrees 
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Another significant variable in this system proved to be the number of cells 
per culture. Experiments were devised in which this number was varied between 
1 X  106 and 50  X  106 cells with  a constant stimulus  of 10 microliters PHA. A 
typical dose response curve of this  type is shown in Fig. 3,  expressed  as ~I-I- 
thymidine incorporation and as ratio of incorporation. For cell numbers below 
3 X  10  ~  per tube, tritiated thymidine incorporation was low both in stimulated 
and unstimulated cells. Above 5 X  106 per tube, the increments of PHA stimu- 
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FIG. 3.  Relation between cell numbers and PHA stimulation.  In this experiment,  C57B1/6 
spleen cells in the indicated  numbers per tube were incubated  48 hr alone, or with 10 micro- 
liters PHA-P for 48 hr; at 24 hr, 3H-thymidine was added. The points represent mean values 
for 3-5 replicate  tubes and the range for PHA-stimulated (O), and control  tubes (Q); the 
ratio of incorporation  (A) was calculated  from the mean values. 
lated incorporation were smaller for the stimulated than the unstimulated cell 
populations, so that a maximum ratio of incorporation with this amount of PHA 
was attained  at 3  to 5 million cells  per tube.  Because constant values for in- 
corporation in unstimulated cells are found over a wide range of cell numbers 
around 15 X  106 cells per tube, this value was chosen for most subsequent ex- 
periments.  In  experiments  for  which  high  discrimination  is  desirable,  or  in 
which  higher  cell  numbers  represented  an  operational  problem,  the  optimal 
ratio of cells to stimulant should be determined. 
Variation was found in the degree of stimulation by PHA in  cultures of cells 
from various strains of mice (Table III). Variability was evident both in  total ADLER,  TAKIGUCHI,  MARSH,  AND  SMITH  1057 
incorporation values and the ratio of incorporation under identical cultural con- 
ditions.  The  greatest  total  incorporation values  were  obtained  in cultures  of 
BALB/C cells; the greatest discrimination observed was by those of C57B1/6. 
DBA-2, by contrast, was minimally stimulated by PHA despite a close genetic 
relationship to BALB/C. B10-LP and B10-M, both congenic sublines of C57B1/ 
10, showed uptake and ratios of incorporation comparable to their stem line. 
The reasons  for strain variations  in responsiveness  to PHA are  not  under- 
stood. It could be related to the number of PHA receptors on the cell surfaces 
involved,  differing sensitivity  to,  or requirements  for,  certain elements  of the 
TABLE  III 
Comparison of Spleen Cells from  Various Mouse Strains in Their Capacity for 
3H-Thymidine Incorporation With and  Without PHA  Stimulation* 
Strain of origin 
ZH-thymidine incorporation (mean and range cpm per tube) 
Control  PHA 
Ratio of 
incor- 
poration: 
PHA/ 
control 
cpm  cpm  cpm  cpm 
A/J  6,407  (5,782-6,831)  168,029  (150,741~175,048)  26.2 
C57B1/6  956  (872-1,095)  119,678  (110,746--127,828)  125.2 
DB A-2  9,238  (8,709--10,009)  56,109  (50,548-62,060)  6.1 
BALB/C  5,695  (4,924-6,193)  318,357  (305,650-345,683)  56.0 
CBA  5,135  (4,687-5,442)  176,836  (169,542-193,090)  34.4 
B10-LP  5,593  (5,028-6,316)  84,205  (73,822-89,969)  15.1 
(A/J X  C57B1/6 F-1  4,556  (4,193-4,975)  179,782  (173,833-186,176)  39.5 
B10-M  4,147  (3,778-5,160)  95,566  ,'84,150-98,895)  23.0 
*In this experiment, a single serum donor was employed for preparation  of the medium in 
order to compare cells from various mouse strains with respect to the background and PHA- 
stimulated  incorporation of 3H-thymidine under identical cultural conditions. 15 X  106 cells 
in 3 ml per tube were incubated with or without PHA for 24 hr; 3H-thymidine was added, and 
the experiment was terminated  at 48 hr. The values given represent  means of 6-8 replicate 
tubes. 
medium in which the stimulation takes place, or differing proportions of PHA- 
sensitive cells in the spleen cell suspension. 
The earliest  experiments  with this  system suggested that the human serum 
component was  an important variable  which  determined  the  degree  and  dis- 
crimination of stimulation. Three elements appear to contribute to this source of 
variability.  First, heat inactivation of the serum at 56°C for 30 min is required 
to negate a  cytotoxic effect of human serum upon mouse spleen cells.  Second, 
the heated serum must be used fresh to achieve consistent and predictable  re- 
sults over a period of time. Storage at 4°C or -20°C for any significant  period 
of time resulted in a medium which gave undependable and variable degrees  of 
stimulation.  The character  of  lability  to  low  temperature  is  at  present  un- 
known. As shown in Table IV, however, and exemplified by experience through- 
out this  period of investigation,  fresh,  heat  inactivated  serum from the  same 1058  CELLULAR  RECOGNITION  BY  LYM:PHOCYTES  IN  VITRO.  I 
donor provides a highly reproducible degree of stimulation to spleen cells of the 
same strain, day to day and week to week. 
The third major component of human serum proved to constitute an absolute 
requirement for mouse cell stimulation under these conditions. This is a naturally 
occurring anti-mouse erythrocyte agglutinin found in the serum of nearly every 
adult human  being.  The  presence  and  titer  of this  agglutinin  was  positively 
TABLE IV 
Stimulation  of Varying Numbers of A/J or C57BI/6  Spleen  Cells by PItA; Day to Day 
Reproducibility of Experimental Results using Same Serum Donor* 
No. of reacting cells 
per tube X  106 
C57B1/6 cells 
1 X  10S/tube 
C57B1/6 cells 
5 X  10S/tube 
C57B1/6 cells 
10 X  10~/tube 
C57B1/6 cells 
15 X  l0 s 
~H-thymidine incorporation  (mean and range 
cpmper tube) 
Control  PHA 
cpm  ]  cpm 
242  (227-260) 
282  (253-325) 
238  (228-246) 
2,393 
2,679 
2,865 
4,856 
4,257 
4,638 
4,020 
4,406 
3,830 
(2,342-2,454) 
(2,501-2,891) 
(2,659-2,985) 
(4,808-4,914) 
(4,148-4,367) 
(4,569-4,708) 
(3,787-4,363) 
(3,998-4,680) 
(3,791-3,892) 
c/m, 
13,025 
11,799 
13,261 
51,821 
72,600 
73,207 
88,335 
94,213 
91,817 
116,248 
124,843 
cpm 
(12,563-13,483  ) 
(10,841-13,536) 
(12,889-13,002) 
(46,626-56,640) 
(68,190-76,425) 
(70,764-75,357) 
(86,416-91,918) 
(92,695-95,731) 
(92,791-96,844) 
(110,180-116,433) 
(118,403-130,723) 
Ratio of 
incorpor- 
ation: 
PHA/ 
control 
54.0 
62.6 
54.5 
21.7 
27.0 
25.3 
18.2 
22.2 
19.8 
29.2 
28.3 
* In each experiment shown, fresh serum from a single donor was used to repeat the same 
experiment on the days as indicated. The number of cells indicated were incubated with or 
without PHA-P, 10 microliters per tube for 24 hr; aH-thymidine was then added and the ex- 
periment terminated at 48 hr. The data given are the mean values and ranges for 3-4 replicate 
tubes done  on the indicated day. 
correlated with 3H-thymidine incorporation of paired control and PHA-stimu- 
lated tubes over the range of titers of 1-5 to 1-40. A  summary of data demon- 
strating this relationship is shown  in Table V. Increasing titers of this agglu- 
tinin  were  correlated  directly with  the  level  of  thymidine  incorporation  in 
PHA-stimulated cultures.  However,  incorporation by  unstimulated  cells  in- 
creased  10-fold over  the same  range  of titers.  Consequently,  the ratio  of in- 
corporation  was  highest  in  medium  containing  low-titered  sera,  and  thus, 
whenever possible, individuals with the lowest titers were employed for all ex- 
periments. It was  also established  within  the  limited  number  of  individuals ADLER,  TAKIGLICHI,  MARSH,  AND  SMITH  1059 
tested, that there is little day to day or week to week variation in the titer in 
any given individual over a period of time. 
Absorption of the human anti-MRBC agglutinin with MRBC, as shown in 
Table V, removed almost all capacity of the medium to support stimulation by 
PHA. The characteristics of the element removed were determined on the eluate 
TABLE V 
Effect of Human Anti-Mouse Erythrocyte A gglutinin on 3H-Thymidine  Incorporation 
by Normal and PHA-Stimulated A/] Spleen Cells* 
Anti-mouse RBC  No. of  ~H-thymldine incorporation (average cpm per  Ratio of 
paired  tube and range)  incorporation:  agglutinin titer of  determi-  PHA/control 
serum donors  nations  Control  PHA 
cpm  @m 
1-5  15  2,113  141,089  68 
(1,364-2,945)  (118,027-182,602) 
1-10  20  8,348  165,232  20 
(4,313-13,244)  (127,694-191,962) 
1-20  16  17,789  176,328  10 
(12,279-31,216)  (115,776-277,967) 
140  16  28,506  245,835  8.2 
(18,400-47,234)  (187,391-288,443) 
1-10  10  101  182  1.8 
(Absorbed with mouse  (45-160)  (51-500) 
RBC$) 
* Data from 67 experiments in  which 15 X 106 A/J spleen cells  in 3 ml medium were stimu- 
lated,  or not, with 10 microliters PHA-P. The media employed for individual experiments 
contained human serum from various donors. The data are arrayed on the basis of the anti- 
mouse erythrocyte agglutinin titer of the donor serum. Each experiment consisted of 3-5 con- 
trol tubes paired with an equal number of ][?HA tubes. The data given here represent  the 
average of the mean values for comparable tubes in each experiment, and the range of values 
observed. 
:~ For these experiments, the medium was made from the serum of a single donor, having a 
1-10 titer. The serum was absorbed with an equal volume of washed A/J erythrocytes and the 
resultant serum used to prepare the medium. 
from MRBC which had been incubated in human serum. Elution by either of 
two techniques (see Materials and Methods)  designed to dissociated antigen- 
antibody complexes yielded into the supernate proteins identified as gamma G 
and gamma M  immunoglobulins. Moreover,  this  eluate had the property of 
combining with and coating mouse tymphoid ceils at 37°C after 30 Inin, as re- 
vealed by ring fluorescence when fluorescein-labeled anti-human fragment III 1060  CELLULAR  RECOGNITION  BY  LYMPHOCYTES  IN  VITRO.  I 
was added. These eluates, moreover, had the property of mediating cytotoxicity 
of mouse  spleen  cells  in  titers  over  1-500,  when  guinea  pig  complement  ab- 
sorbed with  MRBC  was added  to the system.  Therefore,  the major factor in 
human serum necessary to the medium was identified as an anti-mouse lympho- 
cyte globulin  (AMLG).  This  requirement  may be  related  to the  observation 
that  guinea  pig lymphoid cells  are  stimulated  to mitosis  by anti-lymphocyte 
sera and this effect is dose-dependent  (28). 
The stimulatory capacity of the anti-lymphocyte globulin alone in this system 
is shown by the results  of experiments  in which PHA was added  at  intervals 
after establishment  of cultures,  then  incorporation assayed after an additional 
TABLE VI 
Loss of Responsiveness to PHA Stimulation in Long-Term Cultures of C57B1/6 Spleen  Cells* 
3H-thymidlne  incorporation  (mean and range cpm per tube) 
Age of culture 
Ratio of incorporation:  in days  Control  PHA  PHA/control 
cpm  cpm 
3  11,757  42,686  3.6 
(9,435-12,967)  (41,030-43,737) 
6  18,094  38,305  2.1 
(16,813-19,782)  (36,182-43,233) 
10  53,400  56,731  1.06 
(50,600-56,271)  (55,100--58,801) 
* C57B1/6 spleen cells, 15 X  106 per tube were incubated without PHA until 48 hr before 
the indicated age. At that time (I, 4, and 8 days, respectively), PHA, 10 microliters per tube, 
was added to the cell with fresh medium. 24 hr later,  3H-thymidine was added and  the cul- 
tures were terminated  on the indicated  day.  The values  shown represent  mean  and  range 
of 3-5 replicate tubes. 
48 hr in culture.  In such experiments,  illustrated  by that shown in Table VI, 
PHA was added after  1, 4, or 8 days, to cultures of C57B1/6 spleen ceils. These 
results indicate that,  during the course of cultivation in human serum contain- 
ing medium, the cell population becomes progressively refractory. This suggests 
that  AMLG  either  has  preempted  sensitivity  to  the  superimposed  specific 
stimulus, or that the vigorous stimulation of a non-PHA-sensitive component of 
the  cell  population  has  masked  that  of a  PHA-sensitive  component.  It  may 
also be that the PHA-sensitive cell population has not survived in the culture. 
Demonstration  of an  Arginine  Requirement for  £timulalion.--Several  recent 
studies  have  indicated  unique  requirements  for  certain  nonessential  amino 
acids by lymphoid cells, either for growth or for response to mitogenic stimula- 
tion.  Certain  lines  of mouse lymphoma  cells  have  a  growth-limiting  require- 
ment for asparagine  (29);  these cells either  die or fail  to divide in vitro in its ADLER, TAKIGUCHI, MARSH, AND  SMITH  1061 
absence, or they disappear when asparagine deficiency is artificially induced in 
vivo  (30).  It  has  recently been  reported  (31,  32)  that  lymphoid cells are  in- 
hibited from responding to several mitogenic stimuli by a factor extracted from 
Mycoplasma and identified as consisting, in part, of arginase. It was of interest, 
TABLE VII 
Inhibition  of PttA Stimulation  of A/] Spleen Cells in A rginine-Deficient Medium; 
Restoration of Reactivity with Arginine* 
sH-thymidine  uptake of cultures (Mean  per tube and range) 
Medium employed  Ratio of 
Control  PHA  incorporation: 
PHA/control 
Serum A: 
RPMI 1640 
RPMI 1640 plus 200 
mg/liter arginine 
RPMI 1640, arginine- 
deficient 
RPMI 1640 arginine- 
deficient plus 200 rag/ 
liter arginine 
Serum B: 
Dialyzed with RPMI 
1640 
Dialyzed with arginine- 
deficient RPMI 1640; 
arginine-deficient 
RPMI 1640 
Dialyzed with arginine- 
deficient RPMI 1640; 
arginine deficient RPMI 
1640 plus  200  mg/liter 
arginine 
cpm  cpm 
15,821  151,806  9.5 
(15,770-16,001)  (150,556--153,419) 
12,897  156,575  12.2 
(12,317-13,217)  (155,585-157,481) 
7,555  27,956  3.7 
(6,897-8,421)  (23,982-30,172) 
11,456  145,064  12.7 
(10,632-11,972)  (138,783-151,772) 
13,410  112,827  8.4 
(12,854-13,665)  ~9,677-119,577) 
6,323  19,769  3.1 
(5,370-6,957)  (19,454-20,165) 
9,573  95,899  10.1 
(9,015-9,770)  (90,193-101,833) 
* Two experiments in which tubes containing 15 X  106 A/J spleen cells in 3 ml of the vari- 
ous media, composed as indicated, were incubated with or without 10 microliters PHA for 48 
hr. 3H-thymidine  was added at 24 hr, and the cultures terminated at 48 hr. The sera in the 
second experiment shown were dialyzed against two changes of the indicated medium before 
use. The sera for the two experiments shown were taken from different individuals. 
The values given represent means and range of 3-6 replicate tubes. 
therefore, to determine if the apparent superiority of RPMI  1640, as compared 
to other standard media tried might be associated with its very high  arginine 
content. Experiments were designed to detect a requirement for either arginine 
or  asparagine  in  the  stimulation by  PHA  of  3H-thymidine  incorporation by 
mouse spleen cells. Table VII illustrates two experiments in which the require- 1062  CELLIYLAR  RECOGNITION  BY  LYMPttOCYTES  IN  VITRO,  I 
ment of arginine  for stimulation by PHA  was  demonstrated under different 
circumstances.  In  one experiment,  arginine-deficient medium  was  compared 
with regular medium and with that in which arginine-deficient media had been 
replenished to the  original level. It  was  dearly shown  that  incorporation of 
tritiated  thymidine  by PHA-stimulated  cells  was  markedly reduced in  the 
arginine-deficient medium. Moreover, if the arginine  content  of  the medium 
was reduced further by dialysis of the serum against arginine-deficient medium 
as shown in the second illustrative experiment, PHA-stimulated incorporation 
was reduced somewhat more. It was concluded that arginine is a requirement 
for optimal stimulation of mouse lymphoid cells by PHA, but not an absolute 
TABLE VIII 
Comparison of PHA Stimulation of Spleen, Lymph Node, and Thymus Cells  from 
Mature C57Bl/6 Mice* 
Source of cells 
3H-thymidine incorporation (mean and range cpm per tube) 
Control  PHA 
Ratio of 
incorporation: 
PHA/control 
cpm  cpm 
Spleen  8,639  108,321  12.5 
8,569-8,777  95,731-117,592 
Lymph node  306  4,980  16.6 
283-315  4,508--5,419 
Thymus  3,334  12,515  3.8 
3,209-3,411  12,096-12,982 
* In this experiment, 15  >(  106 cells  from the organ indicated in 3 ml of medium per tube, 
were incubated 24 hr. SH-thymidine was then added and the experiment was terminated at 48 
hr. Serum from a  single donor was employed for the medium. The data represent mean and 
range values of 3-4 replicate tubes in each category. 
requirement. Even in the absence of any known source of arginine, some stimu- 
lation occurred in all experiments. No requirements for asparagine could be de- 
tected. The role of arginine appears to be limited to the first 24 hr of the culture 
period; for feeding the cultures additional arginine alone after this period failed 
to support  additional  incorporation which  occurs when  the  cultures  are  fed 
whole medium, as described earlier. 
PHA-Stimulation of Cells from Animals of Different  Age and from Different 
Sources of Lymphoid Tissue.--It has already been established in  other species 
that the stimulatory effect of mitogenic substances is related to the proportion 
of small lymphocytes present in the cell preparation involved. Proportions of 
these cells vary in the spleen, lymph nodes, thymus, thoracic duct contents, and 
the peripheral blood (33). Accordingly, the relative susceptibility to stimulation 
of mouse spleen, lymph node, and thymus cells was examined, since these vary ADLER,  TAKIGUCHI,  MARSH,  AND  SMITH  1063 
considerably in their contents of mature lymphocytes. Results shown in Table 
VIII illustrate the findings. Cells from the spleen gave the highest incorporation 
of thymidine per 15 X  106 cells of the organs studied, but its ratio of incorpora- 
tion was not as high as those from lymph nodes harvested from the axillary and 
neck areas. Thymus cell preparations were stimulated, but minimally, and with 
a low ratio of incorporation. It seems probable that these latter results can be 
explained by the presence in the preparations of lymphoid cells derived from 
thymic stroma or aggregations of lymphoid cells  attached to the thymus. No 
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Fzo. 4.  Age variations in PHA stimulation of C57B1/6 spleen and  thymus cells. Spleen or 
thymus cells were taken from groups of  C57B1/6  mice of the indicated ages; 15  X  10 s ceils 
were cultured per tube together with 10  X PHA-P for a  total period of 48 hr.  8H-thymidine 
was added at 24 hr. The mean value and range of 3H-thymidine incorporation for cells from 
animals of each age group are shown for both stimulated  (Q, spleen;  l,  thymus)  and un- 
stimulated  (C), spleen;  D,  thymus)  cultures.  Serum from  the same donor was used  in  the 
medium throughout this experiment. 
attempt was made to relate the relative numbers  of small lymphocytes and 
other cell types in these preparations to the degree of stimulation. 
The proportion of lymphocytes to other cell types, as well as the absolute 
numbers in the thymus, lymph node, and spleen yary with age (34) ; therefore, 
age was examined as a variable in susceptibility to PHA stimulation. For these 
studies,  experiments were performed by taking  spleen and thymus cells from 
C57B1/6 mice of differing age and comparing the effects of PHA  stimulation. 
Results of this type experiment are shown in Fig. 4. In contrast to the case of 
the human lymphocyte, where PHA stimulation can be demonstrated early in 1064  CELLULAR  RECOGNITION  :BY  LYMPHOCYTES  IN  VITRO.  I 
fetal life (35), relatively little stimulation of the mouse lymphocyte was evident 
at the time of birth.  Only during the 2nd wk of age did susceptibility to PHA 
stimulation become significant. This was accompanied by decreasing values for 
incorporation in the control cultures. As the susceptibility to PHA stimulation 
appeared  with  age in  thymus  ceils,  the  ratio  of incorporation  increased  to  a 
maximum  at 4  wk and thereafter  fell toward the  newborn level by 36 wk of 
age.  Little  change  in  values  of incorporation  by unstimulated  cells  occurred 
throughout the period. 
TABLE IX 
Effect of Thymectomy on Stimulation  of 3H-Thymldine  Incorporation by PHA into 
C57BI/6 Spleen Cells* 
3H-thymidine incorporation into spleen cell cultures of thymectomized or sham operated 
littermates (cpm/tube) 
Ao~  e  Thymectomized  Sham operated 
mice  Ratio:  Ratio: 
Control  PHA  PHA/  Control  PHA  PHA/ 
control  con  trol 
wk 
3  18,052  17,178  0.95  14,475  42,639 
15,759-21,964  14,835-22,388  13,387-15,522  41,311-43,857 
2.9 
4  10,869  11,163  1.1  9,137  63,374  7.0 
9,084-13,275  8,268-13,863  8,140-10,116  56,376-69,837 
5  4,884  7,541  1.6  4,253  86,575  20.4 
4,274-5,195  7,112-8,048  3,922-4,547  82,844-89,073 
* In this experiment, C57B  1/6 mice were thymectomized or sham operated at birth and at 
the indicated intervals,  spleen cells were taken and cultured  (15 X  106 cells per tube) with 
10 microliters PHA for 48 hr. The data shown represent  the mean values and range of 3-5 
replicate tubes. The same serum donor was used for all media. 
Effect  of  Thymectomy  on  PHA  Stimulation  in  Spleen  Cells.--Since  PHA 
stimulation  has  been shown in  other species  to be dependent  upon an intact 
thymus, the effects of thymectomy upon susceptibility of mouse spleen cells to 
stimulation was examined. 
Animals were thymectomized or sham-operated at birth and their spleen cells 
examined in vitro for PHA stimulation by ~H-thymidine incorporation at 3, 4, 
or 5 wk of age. The results are shown in Table IX. 
Incorporation of thymidine as a result of PHA stimulation was markedly in- 
hibited for the first 4 wk of age. At 5 wk, significant PHA stimulation of spleen 
cells  from thymectomized animals  was  seen,  but  the  response  was  much less 
than  the  sham-operated  controls.  It  appears  then  that  in  mice,  as  in  other 
species studied, the response to PHA is abolished by thymectomy and that this ADLER,  TAKIGUCHI~ MARSH~ AND  SMITH  1065 
is, therefore, a thymus-dependent function. It also seems probable that differing 
sensitivity  to  stimulation  of  populations  of  cells  derived  from  the  spleen, 
thymus,  and lymph nodes reflects the proportion of thymus-dependent cells 
which are normally found in these organs. 
Response of Mouse Spleen Cells to Antigen  (Sheep Erythrocytes).--The  studies 
described above led to the establishment of a standard model in which to ex- 
amine the responsiveness to specific 'antigens. In vitro stimulation of spleen cell 
populations from immune and nonimmune mice has been examined for tubercu- 
IOO  O 
x 
y 
unlmmun~zed  • 
ol  i  i  o  o.o,  o.l  d2  &  ~b  ~o 
mg  SRBC  STROMA ADDED I TUBE 
FIG. 5.  CBA mouse spleen cells were taken at the indicated intervals after the donors re- 
ceived 0.1  ml of a  50% suspension of SRBC, intraperitoneally. Varying amounts of SRBC 
stroma were added to tubes containing 15  X  10 ~ cells.  3H-thymidine was added at 48  hr; 
and the cultures terminated at 72 hr. Serum from a single donor was used to constitute the 
medium. The points shown represent mean values of 3-5 replicate tubes. 
lin and sheep erythrocyte antigens. Although sheep erythrocyte stroma repre- 
sents a complex antigen, the system has been used extensively in mouse sys- 
tems for study of populaticn kinetics (36), and individual cells producing anti- 
SRBC  (37)  as well as providing a  stimulus  for eliciting a  putative  primary 
sponse in vitro (38). 
It was found that normal spleen cell populations of CBA mice were stimulated 
significantly by SRBC as illustrated in Fig. 5. Moreover, after a single immuniz- 
ing injection of sheep erythrocytes, enhanced thymidine incorporation was ob- 
served as early as the 2nd day and the maximum value was reached on the 4th 
day after antigen injection. Animals which had been hyperimmunized by re- 1066  CI~LLULAR  RECOGNITION  BY  LYMPEOCYTES  IN  VITRO.  I 
peated injections of sheep erythrocytes showed only slightly greater incorpora- 
tion then those encountering the antigen for the first time, but had less tendency 
to be inhibited at high antigen doses than those cells involved in a first immune 
response. 
Response of Mouse Spleen Cells to Specific Antigen  (Tuberculin).--One  of the 
earliest observations of cellular immunity in vitro was that of Pearmain  (39) 
who showed  that lymphocytes from tuberculin-positive human  beings would 
transform into blasts if treated with tuberculin. This observation has been ex- 
tensively confirmed in human and guinea pig systems (28). However, the lack 
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FIO. 6.  PPD stimulation of BCG-immune spleen cells. Time-course of PPD stimulation of 
~H-thymidine incorporation by spleen cells taken from groups of C57B1/6  mice which had 
received a single immunizing injection of living BCG organisms. Spleen cells were harvested 
at the indicated intervals, and 15 X  106 cells per tube were cultured 72 hr with the amounts 
of PPD indicated. The data shown represent mean 3H-thymidine  incorporation of 3-5 tubes. 
of an in vitro model has not permitted such studies in the mouse, despite ex- 
tensive investigation of effects of immunization with BCG upon the laboratory 
mouse (40). 
Extensive studies have been made of spleen cell reactivity to PPD  in vitro 
at intervals  after immunization of A/J or C57B1/6  mice with BCG given by 
several different routes and  by various  immunizing schedules.  In contrast to 
immunization by intraperitoneal or intravenous routes which induce little or no 
reactivity to PPD in spleen cell populations, subcutaneous administration of a 
relatively small number of living BCG organisms resulted in a specific suscepti- 
bility of spleen cells to PPD stimulation as indicated by 3I-I-thymidine incorpo- 
ration. Fig. 6 illustrates a typical experiment in which spleen cells from groups 
of  BCG-immunized  mice  were  taken  at  intervals  after  immunization  and 
stimulated in vitro with varying amounts of PPD. It will be seen that no stimu- ADLER~ TAKIGUCHI~ MARSH~ AND  SMITH  1067 
lation occurred in ceils taken 1 wk after BCG immunization, but the response 
was evident at 2 wk and maximal at 3 wk. This immune responsiveness rapidly 
diminished and was just detectable 10 wk later, as compared with nonimmune 
cell populations. 
Table X  illustrates the results of other experiments in which replicate cultures 
of spleen cells from BCG immune and normal A/J or C57B1/6 mice were com- 
TABLE X 
PPD Stimulation  of 3It-Thymidine  Incorporation by Spleen Cells from A/J and C57BI/6 
Mice at Intervals after BCG Immunization* 
Mouse strain  PPD added 
and status  #g per tube 
sH-thyraidine uptake of cultures at intervals after immunization 
(Mean cpm per tube =1= s~)~; 
preimmuni- 
zation  1 wk  2 wk  3 wk  4 wk  9 wk 
cpm  @m  ¢pm  cpm  cpm  cpm 
A/J; BCG im-  0  8,067  11,929  10,651  --  13,626  -- 
immunized  4-97  4-251  -t-475  :~273 
1  8,075  --  14,227  --  44,000  -- 
+141  4-381  4-1,190 
5  --  17,804  36,772  --  77,359  -- 
4-757  4-1,505  4-571 
10  9,684  15,948  27,624  --  102,069  -- 
4-140  4-:t=417  ::t=1,112  4-449 
C57B1/6; B CG  0  7,661  7,691  7,930  8,643  ~  5,743 
immunized  4-64  =t=71  4-4-96  4-415  :t:97 
1  8,007  7,352  15,307  27,555  --  5,952 
4-133  4-197  ::t::1,023  4-121  4-141 
5  --  8,282  37,992  46,197  --  12,094 
4-255  4-542  4-893  =t=240 
I0  7,614  9,197  42,406  51,817  --  11,357 
4-78  4-254  ::I:450  4-2,158  4-62 
C57B1/6§  not 
immunized 
No transfer  7,779 
factor; no  4-212 
PPD 
Transfer fac-  7,317 
tor; no PD  -4-279 
Transfer fac-  11,793 
tor;  1/~g  -4-378 
PPD 
Transfer fac-  25,702 
tor;  10 b~g  :1:705 
PPD 
m 
* A/J or C57B1/6 mice were immunized with 0.05 ml of a  12-day culture of BCG subcu- 
taneously, and spleen ceils obtained from pools of animals at the indicated intervals. The in- 
dicated amounts of PPD were added to each tube. 3H-thymidine was added to these cells at 
48 hr and the experiment terminated at 72 hr. 
§ To normal C57B1/6  spleen cells,  incubated at 37°C  for 30  min with 0.1  ml  dialysate 
transfer prepared from PPD  reactive  human peripheral  leukocytes, were  added  either  1 
#g or 10 #g PPD asindicated. 3H-thymidinewas added at 48 hr and the experiment terminated 
at 72 hr. 
The data represent the mean -t-SE of 6 to 10 tubes in each group. Serum from a single 
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pared. These strains showed essentially the same dose respanse curve and time 
course of immunization. The time course of sensitization to PPD stimulation by 
BCG immunization  as measured in  these studies  is almost precisely that  ob- 
served by Blanden  (40)  in  following the  course of the  PPD-induced  footpad 
reaction  in  BCG-treated  mice,  suggesting  a  correlation  between  the  in  vitro 
events and the in vivo phenomenon. 
Stimulation  of Normal  Mouse  Spleen  Cells  by  PPD  after  Adding  Human 
Dialysate  Transfer  Factor.--A  well-established  property  (2l)  of  peripheral 
leukocytes from humans who react to PPD by skin test is the transfer of this re- 
activity  to  other  PPD-negative  individuals.  This  transfer  does  not  require 
whole cells; in fact, it has been demonstrated that a low molecular weight ma- 
terial, extractable from these cells,  has this transfer property. Fireman (22)  has 
found that this dialysate transfer factor transmits PPD  reactivity not only to 
intact individuals,  but  to the peripheral leukocytes of nonsensitive donors.  It 
was of interest to determine whether transfer factor prepared from the periph- 
eral leukocytes of a  tuberculin-positive human  donor would  have sufficiently 
broad species specificity to endow unstimulated mouse spleen cells with a  ca- 
pacity to respond to PPD.  Surprisingly, transfer factor derived from humans 
endowed mouse spleen cells with a  capacity to respond specifically to PPD  in 
vitro with  a  dose  response relationship very much like  that  of mouse spleen 
cells  derived  from  the  BCG-immunized  animals  (Table  X).  The  dialysate 
transfer factor used for these experiments had been established as effective by 
its capacity to endow nonsensitive human lymphocytes with susceptibility to 
in  vitro stimulation  by PPD.  Preliminary  studies  show  that  the  amount  of 
transfer factor requi~ ed to render a given population of mouse spleen cells sus- 
ceptible has  dose-response characteristics,  suggesting  that  above a  threshold 
amount, additional transfer factor gives no additional PPD responsiveness. 
DISCUSSION 
These  studies  show  that  under  the  cell  culture  conditions  described,  long 
term viability, transformation, and cell division of mouse lymphoid cells occurs 
in  response  to  general  mitogens  and  immunologically specific  antigens.  The 
numerous genetic and operational advantages of the mouse can be dependably 
exploited in an in vitro model for cellular recognition and in an analysis of the 
structural  and  functional  consequences  of  stimulation.  Three  elements  have 
been identified  as necessary to mitogenic stimulation  in  this  model:  (a)  a  re- 
quirement  in  the medium for a  naturally occurring  antibody to  a  membrane 
component; (b) a relative requirement for arginine; and (c) an influence of age 
and neonatal  thymectomy on susceptibility to stimulation by PHA. Through 
exploration of these variables which require control in order to yield reproduci- 
ble data, some understanding of the mechanism can be obtained. 
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broad specificity for mouse cells, agglutinating not only erythrocytes, but spleen 
and lymph node cells.  When eluted from mouse erythrocytes, the  agglutinin 
activity was  contained in  immunoglobulins  of the gamma  G  and gamma M 
classes.  These eluates were hemolytic and cytotoxic for spleen cells in the pres- 
ence of complement. The eluate bound to lymphocyte membranes, as revealed 
by  the  indirect  fluorescent technique.  The  interreaction,  therefore,  had  the 
characteristics of specific antibody combining with a membrane antigen or re- 
ceptor,  and  the  antibody involved has  been termed  anti-mouse lymphocyte 
globulin (AMLG). 
AMLG, thus characterized, has most of the attributes described by Landy 
and associates (41) to a ubiquitous natural antibody in human serum which was 
cytotoxic for sarcoma-37  cells of mouse origin. This antibody was found not 
only in human serum, but in serum of other primates, cows, some rabbits, dogs, 
birds  and  cats; but not in  horse, sheep,  guinea pig, mouse,  rat,  or fetal calf 
serum. This antibody was absorbed from serum by lymphoreticular cells and, 
to a much lesser extent, by muscle and kidney cells. 
Nothing  is  currently known  of the  specific receptor or  antigen  on mouse 
lymphoreticular cells to which AMLG might be directed. By analogy to other 
natural antibodies showing broad specificity, such as the ABO and MN blood 
groups, Forssmann and other heterophile antibodies, membrane-bound muco- 
polysaccharide receptors seem highly probable. 
When this receptor was engaged by AMLG in low concentration, a popula- 
tion of lymphoid cells derived from spleen or lymph node were made susceptible 
to PHA stimulation. The AMLG also permitted cell transformation and DNA 
synthesis in populations of immune cells when specific antigen was added, and it 
allowed detection of primary antigens  and  immune  recognition of histocom- 
patibility antigens (13). 
Several mechanisms by which AMLG might exert these effects are conceiv- 
able.  One  is  that  it  affects directly the  initial  recognition process,  i.e.,  that 
AMLG functions by generating or unmasking recognition receptors on the cell 
membrane. A second possibility is that it functions only by supporting or en- 
hancing the consequences of recognition in terms of the cell transformation and 
cell division assayed in these studies. A third possibility is that it acts to favor 
the operation of a two cell system. 
The first proposed mechanism could be a two-step process in which sterically 
inaccessible  receptors  are  unmasked  by  AMLG-produced  conformational 
changes, permitting interaction of the antigen or PHA, and a  sterically com- 
plementary membrane receptor. Evidence for masking of surface receptors by 
polysaccharides is available (42, 43) in the case of PHA on human lymphoblas- 
told cell lines (44)  and immunoglobulin receptors on lymphoblastoid cell lines 
(45). A more complex mechanism of receptor generation might involve mem- 
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enon is referred to as antigenic modulation (46).  The rapid appearance of the 
earliest consequences of recognition place severe restrictions on the hypotheses 
involving receptor generation by any mechanism. Ramseier (9)  and Granger 
(10) reported experiments, for example, showing evidence of release of chelno- 
tactic or cytotoxic factors into the medium, within 4 hr, as a  consequence of 
specific  in vitro recognition by mouse cells.  The medium employed in both 
studies cited contained calf serum, which probably contained AMLG activity. 
Antigenic modulation in the thymic leukemia (TL)  system occurs, however, 
with  sufficient rapidity  to  be  compatible  with  such  early  events.  Arguing 
against this general type of hypothesis is the observation that receptors for 
PHA are already present on the cell membrane of rat thoracic duct lympho- 
cytes (47), and therefore do not require generation. The evidence available does 
not rule out receptor generation or unmasking as the explanation for AMLG 
function in the mouse system, but it provides no direct support for this hy- 
pothesis. 
The data reported here are also compatible with the second type of hypothe- 
sis; that AMLG has a function in supporting the consequences of recognition 
with no effect on actual receptors themselves. Evidence for this type mecha- 
nism includes the observation that when AMLG is present in high concentra- 
tions, spleen or lymph node populations were stimulated, sui generis, to undergo 
transformation and mitosis,  as  revealed by a  greatly increased background 
incorporation of tritiated thymidine. PHA is also required in relatively high 
concentration for other in vitro models for cell-cell recognition in  the mouse, 
which have been described by others (48, 49).  In these experiments, the PHA 
effect has been ascribed to a capacity to agglutinate and approximate cell sur- 
faces and thus facilitate recognition. In experiments reported here, mouse cells 
were not stimulated to divide by PHA in the absence of AMLG, despite the 
marked agglutination produced by PHA. These data suggest that the AMLG 
membrane receptor is  not the same  as that believed to interact with PHA, 
namely N-acetyl-galactosamine (50).  The data do not exclude aggregation by 
AMLG as significant to its capacity to promote other specific recognition reac- 
tions. 
Experiments  which  bear  upon  the  third  mechanism which  proposes  that 
AMLG promotes interactions in a two cell system are those in which the donors 
of  cells  were  thymectomized during the  newborn  period.  Responsiveness to 
PHA stimulation was virtually abolished, but the  "background" level of in- 
corporation of 3H-thymidine was not lower than in sham-operated controls. 
Stimulation of DNA synthesis by PHA in mouse spleen cell popttlations, there- 
fore, appears to be a thymus-dependent function, presumably due to the pres- 
ence of a  population of thymus-derived cells.  This  conclusion is  compatible 
with data derived from other animal cell populations studied in vitro (51, 52), 
and in vivo (53),  and with data on congenital th3nnic deficiency of children 
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A second population of cells is present which is not thymus-dependent but 
which interacts with AMLG and initiates the DNA synthesis which constitutes 
the background incorporation levels. In experiments pertinent to this concept, 
to be reported elsewhere (56), two populations of mouse spleen cells were sepa- 
rated by albumin density gradient centrifugation. These populations differed 
markedly in their behavior in this in vitro system. High density small lympho- 
cytes were stimulated by PHA  and some specific  antigens, but showed low 
background activity. Low density, large lymphoid cells  were responsible for 
most of the background incorporation, but showed a lesser capacity to respond 
to PHA, and no response to PPD. 
If it is accepted that two cell types are present in the complete in vitro sys- 
tem, the question is unresolved as to the role, if any, of the cell population which 
is non-thymus-dependent, and which is stimulated to initiate DNA synthesis 
by AMLG alone. If the two cell  systems act together,  the non-thymus-de- 
pendent cell population could conceivably be stimulated by AMLG to yield 
into its immediate environment factors which favor cell survival and cell  di- 
vision in the thymus-derived population. The latter cells would thereby be per- 
mitted to respond to specific antigens. 
It is conceivable also that the thymus-derived and non-thymus-dependent 
population represents independent components of a complex mixture of cells in 
the spleen or lymph nodes. The response stimulated in the former would be ir- 
relevant to the PHA or antigen-specific responses of the thymus-derived popu- 
lations and represent simply the noise level of the technique. If this were the 
case, it would require that AM_LG acts directly upon the cell membrane of the 
PHA- or antigen-responding cell as a costimulant to permit recognition or en- 
hance viability and cell division. 
Each of the hypotheses proposed to explain the function of AMLG in this 
system is compatible with existing data, and susceptible to further experimental 
testing. The concept of two independent cell systems with AMLG acting as a 
costimulant in the PHA or antigen-responsive population is favored by the 
most positive evidence available. However, no hypothesis in current form per- 
mits a full explanation of the nearly absolute requirement for AMLG for in 
vitro cell stimulation. 
A  second requirement of in vitro stimulation of mouse lymphoid cells was 
arginine. In an arginine-deficient medium, both background and PHA-initiated 
DNA synthesis were inhibited. Thus it seems probable that the arginine re- 
quirement  is  related  to  postrecognition events.  Unlike  the  requirement  for 
AMLG, the arginine effect was not absolute; deficiency did not abolish either 
type of stimulation. While this work was in progress, it was found (30, 31) that 
arginine was  required for PHA-stimulated and  specifically stimulated blast 
transformation of human and rabbit lymphocytes, and that the deficiency was 
also relative.  Arginine was  also  required for DNA  synthesis and growth of 
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infectious mononucleosis, or from biopsy specimens from patients with Burkitt's 
lymphoma (57). 
No known biochemical pathway for arginine metabolism appears to explain 
these phenomena. An entirely different category of effects of arginine might ac- 
tually be postulated--namely effects analogous to those of polylysine and othe~ 
charged compounds in stimulation of micropinocytosis in macrophages (58). It 
is known that the arginine content of transformed lymphoid cells is higher than 
the unstimulated lymphocyte (59) and  it  is  conceivable that  this  represents 
actively stimulated pinocytotic admission to the cytoplasm. 
The age-related response of populations of lymphoid cells to PHA and other 
stimuli defines an operational variable which must be standardized for consist- 
ent results in this in vitro system. Beyond that, however, the data indicate that 
an in vitro equivalent exists for the well-established deficiency of newborn mice 
in responding to certain types of antigenic stimulation (60-62). 
The general hyporeactivity of newborn mice to antigens has not been ade- 
quately explained. Argyris (63) has reported evidence that an element of im- 
munologic hyporeactivity in the newborn mouse may be macrophage deficiency. 
The capacity to produce plaque-forming units in response to sheep erythrocyte 
immunization was augmented up to seven-fold by transferred syngeneic peri- 
toneal exudate cells.  She has suggested that the immaturity of the lympho- 
reticular system in newborn mice might be related to ineffective antigen proc- 
essing or antigen localization. 
In the system reported here,  PHA-stimulated thymidine incorporation by 
populations of spleen cells was essentially nil, prior to 7 days of age, after which 
it rose rapidly to a maximal response by 40 days. The background level of in- 
corporation, on the other hand, was relatively high at birth and thereafter fell 
progressively. These data might be interpreted as defining two populations of 
cells;  one population which  gives  background  thymidine incorporation,  but 
which cannot itself respond to PHA, and a second which is PHA-sensitive, pre- 
sumably thymus-derived, but absent from the spleen  at birth.  However,  in 
newborn mice, as contrasted to thymectomized mice, background incorporation 
may represent ongoing cell division in a population of hematopoietic cells known 
to be present in the newborn spleen. The failure to demonstrate PHA-responsive 
cells  at birth in the mouse is also inconsistent with reported susceptibility to 
PHA stimulation of newborn or fetal b~aphoid cells of humans (34, 35, 64). The 
possibility should be considered, therefore, that lack of PI-IA responsiveness in 
newborn mouse cells  is  not necessarily related  to  the  absence  of responsive 
cells, but to a deficiency of the AMLG receptors. Such a mechanism has prece- 
dence in the observation that newborn mouse lymphoid cells lack, in their sur- 
face membrane, representative adult levels of histocompatibility antigens (13, 
65). 
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actions between specific antigens and populations of immune cells as compared 
with nonimmune cells. The two antigens examined thus far, SRBC stroma and 
PPD, have given results which are similar in many respects. The general dose- 
response relationship in terms of incorporation of 3H-thymidine were similar in 
both systems; stimulation increased with increasing concentrations of antigen 
until a maximum value was reached. Addition of more antigen beyond this point 
gave  progressive  inhibition  of  incorporation.  The  concentration  of  antigen 
which gave maximal stimulation  in both systems varied in ceils obtained at 
various times during the course of immunization. For example, a concentration 
of SRBC stroma which was maximally stimulating to cells taken at 4 days post- 
immunization was inhibitory to cells taken at 3 or 10 days postimmunization. 
Presumably, this dose-response relationship reflects the number of antigen- 
sensitive cells in the spleen population at the time assayed. It might be assumed 
that each of the cells requires an equivalent number of antigen hits to reach the 
threshold  which  stimulates  DNA  synthesis.  In  this  case,  the  dose-response 
curve should reflect the amount of antigen required to trigger each member of 
the antigen-sensitive population present at any given time after immunization. 
This should give a plateau incorporation level, rather than inhibition in high 
doses. By analogy to antigen-antibody complexes, it might be postulated that 
antigen responsiveness in  terms of DNA  synthesis  induced requires  antigen 
bridges between antigen sensitive cells,  a lattice effect. Excess antigen could 
combine with all sites on the reactive cells and block this effect, thus inhibiting 
DNA synthesis. It is also possible that excess antigen, beyond that required for 
maximum stimulation, is in some way cytotoxic or specifically inhibitory to the 
antigen-driven processes which usually lead to cell division. 
The time-course of the specific response assayed in vitro differs in SRBC- and 
BCG-immunized mice. In the former, the earliest increase over background is at 
about 60 hr; it reaches a maximum level at 4-5 days and declines thereafter. 
This parallels very closely the timing of cellular reflections of antibody forma- 
tion in  the  spleen  after comparable immunization  (66).  BCG immunization 
initiates a slower tempo of cellular events, with earliest increase in incorpora- 
tion occurring at the 2nd wk, the maximum achieved at 3-4 wk, and the re- 
sponse declining thereafter. This course follows the in vivo manifestations of 
delayed hypersensitivity in the mouse (40). 
In both systems, however, and in the immune responses to alloantigens (13), 
the ultimate outcome is that susceptibility to specific stimulation in spleen cell 
populations returns  to the preimmunization background level. This had  oc- 
curred by 10--15 days after immunization in the case of SRBC stroma, by 10 
wk after BCG, and by 2 wk after alloantigen injection (13). At face value, these 
data indicate that no greater number of antigen-sensitive cells exist after an 
antigenic experience, even a  presumably de  novo  one like BCG, than existed 
prior to immunization, i.e., that no memory cells were produced. A further im- 1074  CELLULAR RECOGNITION  BY  LY•PItOCYTES  IN  VITRO.  I 
plication is that no memory occurs in the absence of antigen and that the pro- 
liferative response initiated by antigen  is  self-limiting and  returns  to  a  pre- 
existing state when the stimulus to cell division is gone. This is clearly not the 
case in spleen cell populations where antibody formation by individual cells is 
assayed in vitro as a  response to immunization (67).  Here, an easily detected 
increment of memory cells accrues in the spleen after an antigenic experience 
with SRBC stroma. No similar comparison in the case of BCG and alloantigens 
has been made. The cell population which responds to SRBC stimulation by 
making and secreting antibody appears to represent a memory system, and the 
population which is stimulated to divide and to mediate delayed hypersensi- 
tivity-type phenomena are antigen driven, but do not increase the numbers of 
progeny having similar properties. A corollary of this line of speculation would 
be that the latter population must be replenished regularly from stem cells by 
thymic derivation. It is possible, and difficult to rule out, that the increment of 
added antigen-sensitive cells  required  for memory--a  more  rapid  and  aug- 
mented response to reencountered antigen--is small, and the system employed 
here is too insensitive to detect it.  More information is needed on sensitivity 
before this question can be resolved, and the credibility of the memory concept 
stated above can be evaluated critically. 
SUM)£ARY 
The media and culture conditions required for in vitro stimulation of mouse 
lymphoid cells  are  described.  The medium  was  arginine-rich  and  contained 
heat-inactivated human serum. A component of the human sera necessary for 
stimulation of the cells was a natural mouse cell agglutinin, which affected both 
background  stimulation  and  the  degree  of induced stimulation  with  phyto- 
hemagglutinin  (PHA).  Absorption  of the  agglutinin  from the  human  serum 
rendered the medium incapable of sustaining DNA synthesis in the presence of 
PHA. 
The response to PHA of mouse spleen and thymus cells was age-dependent 
and, although this response was not present at birth, it rapidly rose to adult 
levels. Spleen cells from mice immunized with bacillus Calmette-Gu~rin (BCG) 
or sheep erythrocytes (SRBC)  showed increased in vitro reactivity to added 
purified protein derivative (PPD) or SRBC stroma, dependent on the time of 
immunization. 
The dose response curve for the SRBC stroma stimulated,  immune spleen 
cells is compatible with a theory of cell to cell interaction being necessary for an 
in vitro reaction to antigen. 
The possible role of the mouse cell agglutinin (AMLG) is discussed. 
We would  like  to  thank  Mrs.  Penny Marquette  for  her  help  in  the preparation  of  this 
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